EDWARDS LIFESCIENCES CORPORATION 
Item 5.07. Submission of Matters to a Vote of Security Holders
On
(i) Proposal 1: All the nominees for director listed in Proposal 1 were elected
to serve until the Company's next annual meeting of stockholders and until
their respective successors are duly elected and qualified as set forth
below:
Nominee For Against Abstain Broker Non-Votes
Kieran T. Gallahue 496,404,345 4,432,894 1,012,081 34,783,895
Leslie H. Heisz 494,244,025 6,613,299 991,996 34,783,895
Paul A. LaViolette 486,870,991 12,787,727 2,190,602 34,783,895
Steven R. Loranger 496,378,158 4,443,869 1,027,293 34,783,895
Martha H. Marsh 488,028,962 11,684,241 2,136,117 34,783,895
Michael A. Mussallem 472,478,154 27,021,021 2,350,144 34,783,895
Ramona Sequeira 496,428,871 4,415,266 1,005,183 34,783,895
Nicholas J. Valeriani 435,251,614 62,067,208 4,530,498 34,783,895
(ii) Proposal 2: The advisory proposal regarding the Company's named executive
officer compensation was approved as set forth below:
For Against Abstain Broker Non-Votes 450,501,744 49,851,515 1,494,852 34,785,104
(iii) Proposal 3: Ratification of the appointment of
as the Company's independent registered public accounting firm for the
fiscal year ending December 31, 2022 was approved as set forth below:
For Against Abstain Broker Non-Votes
503,259,534 31,880,888 1,492,794 0
(iv) Proposal 4: The advisory stockholder proposal to reduce the share ownership
threshold to call a special meeting was not approved as set forth below:
For Against Abstain Broker Non-Votes
181,606,510 314,986,360 5,255,241 34,785,104
--------------------------------------------------------------------------------
© Edgar Online, source
